Analysis of systemic inflammatory response in the carcinogenic process of uterine cervical neoplasia


Autoria(s): Lopes e Lages, Elisa; Belo, Andrezza Vilaca; Andrade, Silvia Passos; Rocha, Monaliza Angela; Freitas, Gustavo Ferreira de; Lamaita, Rivia Mara; Traiman, Paulo; Silva-Filho, Agnaldo Lopes
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/10/2011

Resumo

The inflammatory response is an active process in cervical cancer and may act in the progression and/or regression of the lesion. At the site of inflammation, macrophages and neutrophils are present as well as cytokines such as TNF-alpha and IFN-gamma. This study aims to evaluate the inflammatory response levels in women with cervical intraepithelial lesions (CIN) and with squamous cell carcinoma (SCC) of the cervix. Serum samples obtained from women without evidence of disease (n = 30), with CIN (n = 30) and with SCC of the cervix (n = 30) were analyzed for the activities of N-acetylglucosaminidase (NAG) and myeloperoxidase (MPO) by enzymatic assay and the serum levels of TNF-alpha and IFN-gamma by ELISA assay. The activities of NAG and MPO and the level of TNF-alpha were higher in women with CIN compared to the women with SCC. The levels of IFN-gamma were lower in the group of women with CIN compared to the group with SCC. There was not a significant association between the degree of the CIN and the staging of the SCC of the cervix and the degree of inflammation as assessed by the levels of inflammatory markers. The inflammatory response was inversely correlated with the progression of the carcinogenic process. In the three groups, the control group, women with CIN and women with invasive SCC, there was no association between the degree of preinvasive lesions and staging of the SCC of the cervix. (C) 2011 Elsevier Masson SAS. All rights reserved.

Formato

496-499

Identificador

http://dx.doi.org/10.1016/j.biopha.2011.06.010

Biomedicine & Pharmacotherapy. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 65, n. 7, p. 496-499, 2011.

0753-3322

http://hdl.handle.net/11449/12198

10.1016/j.biopha.2011.06.010

WOS:000296965100007

Idioma(s)

eng

Publicador

Elsevier France-editions Scientifiques Medicales Elsevier

Relação

Biomedicine & Pharmacotherapy

Direitos

closedAccess

Palavras-Chave #Cervical cancer #N-acetylglucosaminidase (NAG) #Myeloperoxidase (MPO)
Tipo

info:eu-repo/semantics/article